Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2013 / Cilt: 19 - Sayı: 2

Postpartum Bir Hastada Sublingual Prostaglandin E1 Verilmesinin Ardından Gelişen Ateş ve Akut Konfüzyon: Bir Olgu Sunumu

Fever and Acute Confusion in a Postpartum Patient Following Sublingual Prostaglandin E1Administration: A Case Report

Pages
57–59
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present a case that developed uncontrolled tonic body movements and mild disorientation accom- panying fever after sublingual PG E1administration for treatment of uterine atony.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Postpartum hemorrhage due to uterine atony is a condition that may be life-threatening unless immedi- ate intervention is made.
📊
Key Findings & Data:Oxytocin, ergot derivatives, and prostaglandin (PG) E1are first-line medical treatment options besides an effective uterine fundal massage.
💡
Conclusion & Impact:We present a case that developed uncontrolled tonic body movements and mild disorientation accom- panying fever after sublingual PG E1administration for treatment of uterine atony.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Postpartum hemorrhage due to uterine atony is a condition that may be life-threatening unless immedi- ate intervention is made. Oxytocin, ergot derivatives, and prostaglandin (PG) E1are first-line medical treatment options besides an effective uterine fundal massage. If the patient is unresponsive to the med- ical management approach, surgical intervention is required. All medications have potential side effects. We present a case that developed uncontrolled tonic body movements and mild disorientation accom- panying fever after sublingual PG E1administration for treatment of uterine atony.

Özet

Uterin atoniye bağlı postpartum kanama, acil müdahale edilmezse, yaşamı tehdit edici bir durumdur. Etkili uterin fundal masajın yanında, oksitosin, ergot deriveleri ve prostaglandin E1 ilk medikal tedavi seçenekleridir. Hasta medikal tedaviye cevap vermezse, cerrahi girişim gereklidir. Tüm tedavilerin belli yan etkileri mevcuttur. Uterin atoni tedavisi için sublingual PG E1 verilmesinin ardından ateşe eşlik eden kontrolsüz tonik vücut hareketleri ve hafif dezoryentasyon gelişen bir hastayı vaka olarak sunmaktayız.

🔖

Cite This Article

UYGUR, D., EROL, N., ERDİNÇ, A. S. Ö., SALİH, F., MEMUR, T., ERKAYA, S. (2013). Postpartum Bir Hastada Sublingual Prostaglandin E1 Verilmesinin Ardından Gelişen Ateş ve Akut Konfüzyon: Bir Olgu Sunumu. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 19 - Sayı: 2, 57–59. https://ajindex.com/articles/207803

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Alfirevic Z. Blum J. Walraven G. Weeks A. Winikoff B. Prevention of postpartum hemorrhage with misoprostol. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2007
  2. 99 (Suppl 2):198-201 doi:10.1016/j.ijgo.2007.09.012 2. Hundley VA. Avan BI. Sullivan CJ. Graham WJ. Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings in low-resource countries? A systematic review of the evidence. BJOG: an international journal of obstetrics and gynaecology discussion 2013
  3. 285 doi:10.1111/1471-0528.12049 3. Khan RU. El-Refaey H. Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor. Obstetrics and gynecology 2003
  4. Hofmeyr GJ. Gulmezoglu AM. Misoprostol for the prevention and treatment of postpartum haemorrhage. Best practice & research. Clinical obstetrics & gynaecology 2008
  5. 1041 doi:10.1016/j.bpobgyn.2008. 08.005 5. Durocher J. Bynum J. Leon W. Barrera G. Winikoff B. High fever following postpartum administration of sublingual misoprostol. BJOG: an international journal of obstetrics and gynaecology 2010
  6. doi:10.1111/j. 1471-0528.2010.02564.x 6. Hofmeyr GJ. Gulmezoglu AM. Novikova N. Linder V. Ferreira S. Piaggio G. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and metaanalysis of maternal deaths and dose-related effects. Bulletin of the World Health Organization 2009
  7. Winikoff B. Dabash R. Durocher J. et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Lancet 2010
  8. doi:10.1016/S0140-6736(09) 61924-3 8. Blum J. Winikoff B. Raghavan S. et al. Treatment of postpartum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. Lancet 2010
  9. doi:10.1016/S0140-6736(09)61923-1 9. Raghavan S. Abbas D. Winikoff B. Misoprostol for prevention and treatment of postpartum hemorrhage: what do we know? What is next? International journal of gynaecology and obstetrics: the official organ of the Interna tio - nal Federation of Gynaecology and Obstetrics 2012
  10. 119 (Suppl 1):35-8. doi:10.1016/j.ijgo.2012.03.013 10. Ng PS. Chan AS. Sin WK. Tang LC. Cheung KB. Yuen PM. A multicentre randomized con